Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
46%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
25%
ALSO IN PPH
PPH
27
HOLDINGS
54%
ALSO IN IHE
SECTOR DRIFT (IHE minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 24.6% | 22.7% | 22.7% |
|
MERCK & CO. INC. | 4.5% | 9.6% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% | 4.3% | 4.1% |
|
PFIZER INC | 4.1% | 4.8% | 4.1% |
|
JOHNSON & JOHNSON | 20.8% | 4.1% | 4.1% |
IHE Overweight Relative to PPH
|
JOHNSON & JOHNSON | 16.7% |
|
ROYALTY PHARMA PLC CLASS A | 5.2% |
|
VIATRIS, INC. | 3.8% |
 |
JAZZ PHARMACEUTICALS PLC | 2.8% |
|
ELANCO ANIMAL HEALTH, INC. | 2.8% |
|
ELI LILLY & CO | 1.9% |
|
AXSOME THERAPEUTICS, INC. | 1.9% |
|
CORCEPT THERAPEUTICS INC | 1.4% |
|
LIGAND PHARMACEUTICALS-CL B | 1.2% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.1% |
IHE Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.5% |
|
MERCK & CO. INC. | -5.1% |
 |
SANOFI-AVENTIS-ADR | -4.3% |
|
ABBVIE INC | -4.2% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.2% |
|
ASTRAZENECA PLC-SPONS ADR | -4.1% |
|
MCKESSON CORP | -3.7% |
|
CENCORA INC | -3.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.2% |